Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
Changing maintenance therapy to try to extend remissions for newly diagnosed multiple myeloma
A mid-year review of multiple myeloma with Dana Farber expert Paul Richardson, MD
Learn more about allo CAR T development with myeloma CAR T expert Jesus Berdeja, MD of Sarah Cannon Research Institute
What do we have to look forward to in multiple myeloma care in 2022? Join us for this informative show with myeloma expert Robert Orlowski, MD, PhD
Learn about a new class of immunotherapy called ETBs for the treatment of multiple myeloma with Dr. Shaji Kumar
Learn more about a new myeloma therapy called tasquinimod targeting Myeloid-derived suppressor cells (MDSCs)
Smoldering myeloma is undergoing an evolution in care. When do you treat or not? Dr. Manasanch gives us an update for smoldering myeloma.
Keratopathy is an eye condition that can be associated with a myeloma drug called BLENREP. Learn more about how this can be managed successfully.
Learn from myeloma expert Peter Voorhees, MD about how monoclonal antibodies are being used for newly diagnosed patients for better outcomes
Learn more about AL Amyloidosis with symptoms, treatments and clinical trials.